
PB 15 of 2014
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 19 February 2014
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 1).
(2) This Determination may also be cited as PB 15 of 2014.
2 Commencement
This Determination commences on 1 March 2014.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Aprepitant
Insert
Arachidonic acid and docosahexaenoic acid with carbohydrate
[2] Schedule 1, after item dealing with Carbimazole
Omit
Carbohydrate, fat, vitamins, mineral and trace elements
Insert
Carbohydrate, fat, vitamins, minerals and trace elements
Carbohydrate, fat, vitamins, minerals and trace elements and supplemented with arachidonic acid and docosahexaenoic acid
[3] Schedule 1, after item dealing with Disopyramide
Insert
Docosahexaenoic acid with carbohydrate
[4] Schedule 1, after item dealing with Trifluoperazine
Insert
Triglycerides, long chain